Journal
RHEUMATOLOGY
Volume 56, Issue -, Pages 55-66Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kew427
Keywords
systemic lupus erythematosus; SLE; SLE pathogenesis; autoantibodies; immunology; tolerance; inflammation; tissue destruction
Categories
Funding
- National Institutes of Health (NIH) [AR067625, AI122720]
- Alliance for Lupus Research (ALR) Award [257549]
- ALR [257549]
- NIH [AR067625, AI122720]
Ask authors/readers for more resources
SLE is a chronic autoimmune disease caused by perturbations of the immune system. The clinical presentation is heterogeneous, largely because of the multiple genetic and environmental factors that contribute to disease initiation and progression. Over the last 60 years, there have been a number of significant leaps in our understanding of the immunological mechanisms driving disease processes. We now know that multiple leucocyte subsets, together with inflammatory cytokines, chemokines and regulatory mediators that are normally involved in host protection from invading pathogens, contribute to the inflammatory events leading to tissue destruction and organ failure. In this broad overview, we discuss the main pathways involved in SLE and highlight new findings. We describe the immunological changes that characterize this form of autoimmunity. The major leucocytes that are essential for disease progression are discussed, together with key mediators that propagate the immune response and drive the inflammatory response in SLE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available